Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium electroporation for basal cell carcinomas – proof-of-concept
2019-002730-36Phase 2Completed
- Sponsor
- Department of Dermatology, Bispebjerg Hospital
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of calcium in basal cell carcinoma (BCC), sponsored by Department of Dermatology, Bispebjerg Hospital. Primary endpoint: Clinical tumor response. Started Jul 2019; status: completed.
02
Drugs
calcium
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2019-002730-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002730-36.